Spyre Therapeutics, Inc. (SYRE)
72.47
-0.53
(-0.73%)
USD |
NASDAQ |
May 07, 12:12
Spyre Therapeutics SG&A Expense (TTM) : 35.96M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 29.83M |
| Replimune Group, Inc. | 103.07M |
| Savara, Inc. | 42.06M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Agios Pharmaceuticals, Inc. | 187.06M |